Activate Now
 
ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

The New Dual Activation Pain Relief Cream

The Importance of B Vitamins for Brain Health and Combating Dementia

High serum omega-6 polyunsaturated fatty acid concentrations linked to lower risk of type 2 diabetes

SURVEY RESULTS: Medical Marijuana

Vitamin D supplementation shows promise for Hashimoto's thyroiditis

Recipe: Mega-Golden Milk

A Paleolithic-type diet may help reduce future risk of diabetes and cardiovascular disease

Large whey protein breakfast may help manage type 2 diabetes

Meta-analysis adds evidence to antidepressant effect for omega-3

Higher vitamin C intake may help slow cataract progression

 
Print Page
Email Article

Columbia University Medical Center Researchers Lead Placebo-Controlled Study of Cognitive Impairment Among Patients With Previously Treated Lyme Disease

  [ 143 votes ]   [ Discuss This Article ]
By Columbia University Medical Center • www.ProHealth.com • October 26, 2007


NEW YORK, Released Oct 10, 2007 – Researchers at Columbia University Medical Center have added to the body of literature on Lyme disease with the publication of a study entitled, “A Randomized, Placebo-Controlled Trial of Repeated IV Antibiotic Therapy for Lyme Encephalopathy,” in the October 10 online edition of Neurology.

The study, led by principal investigator Brian Fallon, MD, MPH, director of the recently established Lyme and Tick-borne Disease Research Center at Columbia University Medical Center, involved screening 3,368 patients for potential inclusion. Strict selection criteria included memory impairment and a positive IgG Western blot for Lyme disease at study entry, as well as previous antibiotic treatment for Lyme disease completed at least 4 months before study entry. The research was funded by the National Institute of Neurological Disorders and Stroke (NINDS).

Dr. Fallon and his research team identified patients with cognitive problems that developed after diagnosis with Lyme disease and that persisted or relapsed despite prior treatment.

n The goal was to determine whether patients who have already received the “standard” course of antibiotic treatment (three weeks of IV antibiotic therapy), would benefit from an additional 10 weeks of antibiotic therapy.

n They also set out to determine whether patients would relapse when taken off antibiotics or whether the alleviation of symptoms is sustained or enhanced with time.

After elimination of potential study subjects who did not meet inclusion criteria, only 57 study participants remained (37 patients with a history of Lyme disease and 20 healthy controls). They were divided into three subject groups:

n Patients with a history of treated Lyme disease were randomized to IV treatment with an antibiotic called ceftriaxone for 10 weeks;

n Patients with a history of treated Lyme disease were randomized to IV placebo for 10 weeks; and

n Healthy controls were tested at the same time points as the patients to help to control for the practice effect on neuropsychological testing.

“We set out in this study to learn if a repeated course of antibiotics relieves certain symptoms associated with post-treatment chronic Lyme encephalopathy and to assess whether such symptom relief is sustained after patients are taken off antibiotics,” said Dr. Fallon. “The sample group of 23 patients who received 10 weeks of IV ceftriaxone therapy initially showed moderate improvements in cognition when evaluated at the primary outcome assessment point of 12 weeks; however, the improvement in cognition was not sustained in the 6 month (24 week) assessment.”

According to the paper, patients with greater severity of pain, fatigue or physical dysfunction at the start of the study who were randomized to ceftriaxone treatment reported improvement in these symptoms at week 12, as compared to those patients who were given IV placebo.

For a subset of patients who received IV ceftriaxone who started the study with higher levels of pain or physical functioning impairments, the improvement in pain and physical functioning was sustained to week 24. Whether reported improvement was due to a direct antimicrobial effect of the antibiotic or effects on neurotransmitters is unclear. Of concern in this study is that IV ceftriaxone treatment was associated with serious side effects in about one-quarter of the patients.

The paper concludes, “...considering both the limited duration of cognitive improvement and the risks, 10 weeks of IV ceftriaxone and then 14 weeks of no antibiotic is not an effective strategy for sustained cognitive improvement.”....

Patient Queries: To schedule a research evaluation for possible participation in a research study, please call the Lyme and Tick-borne Disease Research Center at 212-543-6510. [Note: Dr. Fallon’s team is currently recruiting for a study titled “SPECT Imaging of Chronic Lyme Disease vs. Other Disorders”]




Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Mitochondria Ignite™ with NT Factor® Vitamin D3 Extreme™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
Aching for Pain Relief?

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

How Glutathione Can Save Your Life How Glutathione Can Save Your Life
Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel
Olea25 Olive Hydroxytyrosol Hits Astonishing 68,000+ ORAC Antioxidant Value Olea25 Olive Hydroxytyrosol Hits Astonishing 68,000+ ORAC Antioxidant Value
Natural Relief for Soreness, Pain and Swelling – Putting Out the Fire
When a Good Night's Sleep Is Just a Daydream... When a Good Night's Sleep Is Just a Daydream...

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler

· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE AND SAVE 15% NOW*
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map